SOURCE: CLX Medical, Inc.

August 07, 2008 09:45 ET

CLX Medical, Inc. Announces Results of Meetings at AACC Annual Meeting and Clinical Lab Expo

Master Distributor for the European Market Expected to Be Announced Shortly; Terms and Closing Schedule for Additional Acquisition in the Medical Diagnostic Testing Market Was Also Agreed Upon

MURRIETA, CA--(Marketwire - August 7, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which is focused on the launch and distribution of unique medical diagnostic testing products, today updated shareholders on its successful attendance at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held last week at in Washington, DC.

Among the more significant accomplishments achieved by CLX Medical management at the event was reaching agreement with a major European distributor to serve as the sole importer of CLX's subsidiary products into the European market. In the meetings with the targeted master distributor, a marketing strategy for European sales was established, and CLX expects to announce a Letter of Intent with the distributor in the next several days. The name of the company will also be announced at that time.

CLX Medical also met with the current owner and the manufacturer of an additional medical diagnostic testing product, which CLX expects to acquire in the near term. The two companies have reached agreement on acquisition terms and on a timeline for definitive agreement and the close of the acquisition. CLX expects to identify the product, the market opportunity presented by this acquisition and details of its launch plan within the next two weeks.

The AACC event was held from July 27-31 at the Walter E. Washington Convention Center in Washington, DC. AACC's Clinical Lab Expo, the largest gathering of laboratory industry companies in the world, was anticipated to include 1,800 booths and 650 exhibitors. The Expo allows visitors to see and speak to world-leading companies about the latest developments in laboratory medicine. More information on the event can be found at

"Everything we had hoped to accomplish at the AACC Annual Meeting and Clinical Lab Expo was achieved, and we look forward to providing the details of our agreement with our master distributor for Europe in the next several days and of our anticipated acquisition target shortly thereafter," commented Vera Leonard, chief executive officer of CLX Medical. "Our attendance at the event was more than worth the time we spent there, and we hope that CLX shareholders will follow our new releases closely as we follow-up with the details of each of these agreements."

To sign up to receive information by email directly from CLX Medical, Inc. when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit

About CLX Medical, Inc.

CLX Medical, Inc. ( holds a 51% equity interest in Zonda, Inc., which has developed rapid point of care tests for medical and non-medical markets, and CLX recently announced a letter of intent to acquire another rapid diagnostic device for the medical market. CLX has also invested, and holds a common stock position, in ActionView International, Inc. (, a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Medical, Inc. are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Medical's control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications, Inc.
    A. Beyer
    Email Contact